A Population Model of Time-Dependent Changes in Serum Creatinine in (Near)term Neonates with Hypoxic-Ischemic Encephalopathy During and After Therapeutic Hypothermia.

acute kidney injury hypoxic-ischemic encephalopathy neonates population model serum creatinine therapeutic hypothermia time-dependent covariate

Journal

The AAPS journal
ISSN: 1550-7416
Titre abrégé: AAPS J
Pays: United States
ID NLM: 101223209

Informations de publication

Date de publication:
05 12 2023
Historique:
received: 21 04 2023
accepted: 16 08 2023
medline: 7 12 2023
pubmed: 5 12 2023
entrez: 5 12 2023
Statut: epublish

Résumé

The objective was to apply a population model to describe the time course and variability of serum creatinine (sCr) in (near)term neonates with moderate to severe encephalopathy during and after therapeutic hypothermia (TH). The data consisted of sCr observations up to 10 days of postnatal age in neonates who underwent TH during the first 3 days after birth. Available covariates were birth weight (BWT), gestational age (GA), survival, and acute kidney injury (AKI). A previously published population model of sCr kinetics in neonates served as the base model. This model predicted not only sCr but also the glomerular filtration rate normalized by its value at birth (GFR/GFR

Identifiants

pubmed: 38051395
doi: 10.1208/s12248-023-00851-0
pii: 10.1208/s12248-023-00851-0
doi:

Substances chimiques

Creatinine AYI8EX34EU

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

4

Subventions

Organisme : NICHD NIH HHS
ID : P30 HD106451
Pays : United States

Informations de copyright

© 2023. The Author(s).

Références

Chakkarapani AA, Aly H, Benders M, Cotten CM, El-Dib M, Gressens P, Hagberg H, Sabirj H, Wintermark P, Robertson NJ. Therapies for neonatal encephalopathy: targeting the latent, secondary and tertiary phases of evolving brain injury. Sem Fetal Neonatal Med. 2021;26:101256. https://doi.org/10.1016/j.siny.2021.101256 .
doi: 10.1016/j.siny.2021.101256
Abate BB, Bimerew M, Gebremichael B, Mengesha Kassie A, Kassaw M, Gebremeskel T, Bayih WA. Effects of therapeutic hypothermia on death among asphyxiated neonates with hypoxic ischemic encephalopathy: a systematic review and meta-analysis of randomized control trials. PLoS ONE. 2021;16:e0247229. https://doi.org/10.1371/journal.pone.0247229 .
doi: 10.1371/journal.pone.0247229 pubmed: 33630892 pmcid: 7906350
Segar JL, Chock VY-L, Harer MW, Selewski DT, Askenazi DJ. Fluid management, electrolytes imbalance and renal management in neonates with neonatal encephalopathy treated with hypothermia. Sem Fetal Neonatal Med. 2021;26:101261. https://doi.org/10.1016/j.siny.2021.101261 .
doi: 10.1016/j.siny.2021.101261
Kirkley MJ, Boohaker L, Griffin R, Soranno DE, Gien J, Askenazi D, Gist KM. Acute kidney injury in neonatal encephalopathy: an evaluation of the AWAKEN database. Pediatr Nephrol. 2019;34:169–76. https://doi.org/10.1007/s00467-018-4068-2 .
doi: 10.1007/s00467-018-4068-2 pubmed: 30155763
van Wincoop M, de Bijl-Marcus K, Lilien M, van den Hoogen A, Groenendaal F. Effect of therapeutic hypothermia on renal and myocardial function in asphyxiated (near) term neonates: a systematic review and meta-analysis. PLoS ONE. 2021;16:e0247403. https://doi.org/10.1371/journal.pone.0247403 .
doi: 10.1371/journal.pone.0247403 pubmed: 33630895 pmcid: 7906340
Lutz IC, Allegaert K, de Hoon JN, Marynissen H. Pharmacokinetics during therapeutic hypothermia for neonatal hypoxic ischaemic encephalopathy: a literature review. BMJ Paediatr Open. 2020;4:e000685. https://doi.org/10.1136/bmjpo-2020-000685 .
doi: 10.1136/bmjpo-2020-000685 pubmed: 32577535 pmcid: 7299043
Deferm N, Annink KV, Faelens R, Schroth M, Maiwald CA, Bakkali LE, van Bel F, Benders MJNL, van Weissenbruch MM, Hagen A, Smits A, Annaert P, Franz AR, Allegaert K. ALBINO Study Group, Glomerular filtration rate in asphyxiated neonates under therapeutic whole-body hypothermia, quantified by mannitol clearance. Clin Pharmacokinet. 2021;60:897–906. https://doi.org/10.1007/s40262-021-00991-6 .
doi: 10.1007/s40262-021-00991-6 pubmed: 33611729 pmcid: 8249265
Borloo N, Smits A, Thewissen L, Annaert P, Allegaert K. Creatinine trends and patterns in neonates undergoing whole body hypothermia: a systematic review. Children. 2021;8:475. https://doi.org/10.3390/children8060475 .
doi: 10.3390/children8060475 pubmed: 34200017 pmcid: 8228260
Favié LMA, de Haan TR, Bijleveld YA, Rademaker CMA, Egberts TCG, Nuytemans DHGM, Mathôt RAA, Groenendaal F, Huitema ADR. Prediction of drug exposure in critically ill encephalopathic neonates treated with therapeutic hypothermia based on a pooled population pharmacokinetic analysis of seven drugs and five metabolites. Clin Pharmacol Ther. 2020;108:1098–106. https://doi.org/10.1002/cpt.1917 .
doi: 10.1002/cpt.1917 pubmed: 32463940 pmcid: 7689752
Smits A, Annaert P, Van Cruchten S, Allegaert K. A Physiology-based pharmacokinetic framework to support drug development and dose precision during therapeutic hypothermia in neonates. Front Pharmacol. 2020;11:587. https://doi.org/10.3389/fphar.2020.00587 .
doi: 10.3389/fphar.2020.00587 pubmed: 32477113 pmcid: 7237643
Cristea S, Smits A, Kulo A, Knibbe CAJ, van Weissenbruch M, Krekels EHJ, Allegaert K. Amikacin pharmacokinetics to optimize dosing in neonates with perinatal asphyxia treated with hypothermia. Antimicrob Agents Chemother. 2017;61:e01282-e1317. https://doi.org/10.1128/AAC.01282-17 .
doi: 10.1128/AAC.01282-17 pubmed: 28993332 pmcid: 5700363
Krzyzanski W, Smits A, Van Den Anker J, Allegaert K, Population model of serum creatinine as time-dependent covariate in neonates. AAPS J 2021; 23: Art 86. https://doi.org/10.1208/s12248-021-00612-x .
Keles E, Wintermark P, Groenendaal F, Borloo N, Smits A, Laenen A, Mekahli D, Annaert P, Sahin S, Öncel MY, Chock V, Armangil D, Koc E, Battin MR, Frymoyer A, Allegaert K. Serum creatinine patterns in neonates treated with therapeutic hypothermia for neonatal encephalopathy. Neonatology. 2022;119:686–94. https://doi.org/10.1159/000525574 .
doi: 10.1159/000525574 pubmed: 35797956
The R Project for Statistical Computing. https://www.r-project.org/ . Accessed November 2022.
Bonate PL. Pharmacokinetic-pharmacodynamic modeling and simulation. 2nd ed. New York: Springer Science; 2011.
doi: 10.1007/978-1-4419-9485-1
Valerio E, Mardegan V, Stocchero M, Cavicchiolo ME, Pirillo P, Poloniato G, D’Onofrio G, Bonadies L, Giordano G, Baraldi E. Urinary metabotypes of newborns with perinatal asphyxia undergoing therapeutic hypothermia. PLoS ONE. 2022;17:e0273175. https://doi.org/10.1371/journal.pone.0273175 .
doi: 10.1371/journal.pone.0273175 pubmed: 35972970 pmcid: 9380923
O’Hanlon CJ, Holford N, Sumpter A, Al-Sallami HS. Consistent methods for fat-free mass, creatinine clearance, and glomerular filtration rate to describe renal function from neonates to adults. CPT Pharmacometrics Syst Pharmacol. 2023;12:401–12. https://doi.org/10.1002/psp4.12924 .
doi: 10.1002/psp4.12924 pubmed: 36691877 pmcid: 10014044
Grimsley C, Thomson AH. Pharmacokinetics and dose requirements of vancomycin in neonates. Arch Dis Child Fetal Neonatal Ed. 1999;81:F221–7. https://doi.org/10.1136/fn.81.3.f221 .
doi: 10.1136/fn.81.3.f221 pubmed: 10525029 pmcid: 1721000
Chock VY, Cho SH, Frymoyer A. Aminophylline for renal protection in neonatal hypoxic-ischemic encephalopathy in the era of therapeutic hypothermia. Pediatr Res. 2021;89:974–80. https://doi.org/10.1038/s41390-020-0999-y .
doi: 10.1038/s41390-020-0999-y pubmed: 32503030
Smeets NJL, IntHout J, van der Burgh MJP, Schwartz GJ, Schreuder MF, de Wildt SN. Maturation of GFR in term-born neonates: an individual participant data meta-analysis. J Am Soc Nephrol. 2022;33:1277–92. https://doi.org/10.1681/ASN.2021101326 .
doi: 10.1681/ASN.2021101326 pubmed: 35474022 pmcid: 9257816

Auteurs

Wojciech Krzyzanski (W)

Department of Pharmaceutical Sciences, University at Buffalo, 370 Pharmacy Building, Buffalo, New York, 14214, USA.

Pia Wintermark (P)

Division of Newborn Medicine, Department of Pediatrics, McGill University, Montreal Children's Hospital, Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada.

Pieter Annaert (P)

Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Louvain, Belgium.

Floris Groenendaal (F)

Department of Neonatology, Wilhelmina Children's Hospital, University Medical Center Utrecht, and Utrecht University, Utrecht, The Netherlands.
Utrecht Brain Center, University Medical Center Utrecht, Utrecht, The Netherlands.

Suzan Şahin (S)

Department of Neonatology, Faculty of Medicine, Izmir Demokrasi University, Izmir, Turkey.

Mehmet Yekta Öncel (MY)

Department of Neonatology, Faculty of Medicine, İzmir Katip Çelebi University, İzmir, Turkey.

Didem Armangil (D)

Neonatal Intensive Care Unit, Koru Hospital, Ankara, Turkey.

Esin Koc (E)

Department of Neonatology, Faculty of Medicine, Gazi University, Ankara, Turkey.

Malcolm R Battin (MR)

Newborn Service, Auckland District Health Board, Auckland, New Zealand.

Alistair J Gunn (AJ)

Department of Physiology, University of Auckland, Auckland, New Zealand.

Adam Frymoyer (A)

Neonatal and Developmental Medicine, Stanford University School of Medicine, Palo Alto, California, USA.

Valerie Y-L Chock (VY)

Neonatal and Developmental Medicine, Stanford University School of Medicine, Palo Alto, California, USA.

Elif Keles (E)

Department of Neonatology, Faculty of Medicine, Gazi University, Ankara, Turkey.

Djalila Mekahli (D)

Department of Pediatric Nephrology, University Hospitals, Louvain, Belgium.
PKD Research Group, Department of Cellular and Molecular Medicine, KU Leuven, Louvain, Belgium.

John van den Anker (J)

Division of Clinical Pharmacology, Children's National Hospital, Washington, District of Columbia, USA.
Division of Paediatric Pharmacology and Pharmacometrics, University Children's Hospital Basel, University of Basel, Basel, Switzerland.

Anne Smits (A)

Department of Development and Regeneration, KU Leuven, Louvain, Belgium.
Neonatal Intensive Care Unit, University Hospitals Leuven, Louvain, Belgium.

Karel Allegaert (K)

Department of Pharmaceutical Sciences, University at Buffalo, 370 Pharmacy Building, Buffalo, New York, 14214, USA. k.allegaert@erasmusmc.nl.
Division of Paediatric Pharmacology and Pharmacometrics, University Children's Hospital Basel, University of Basel, Basel, Switzerland. k.allegaert@erasmusmc.nl.
Department of Development and Regeneration, KU Leuven, Louvain, Belgium. k.allegaert@erasmusmc.nl.
Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, 3000, Louvain, Belgium. k.allegaert@erasmusmc.nl.
Department of Hospital Pharmacy, Erasmus MC University Medical Center, 3015, Rotterdam, The Netherlands. k.allegaert@erasmusmc.nl.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH